# Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)

> **NCT01279798** · — · NO_LONGER_AVAILABLE · sponsor: **NovaRx Corporation**

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** Lucanix® (belagenpumatucel-L)

## Key facts

- **NCT ID:** NCT01279798
- **Lead sponsor:** NovaRx Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01279798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01279798, "Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01279798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*